Adam, Gamraida A.

HRN: 18-66-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2024
AMPICILLIN 1GM (VIAL)
12/20/2024
12/26/2024
IV
2g
Q6hr
PROM X 3HRS
Waiting Final Action 
12/21/2024
CEFUROXIME 500MG (TAB)
12/21/2024
12/27/2024
ORAL
500 Mg
BID
Sp NSVD
Waiting Final Action 
12/23/2024
CEFUROXIME 1.5GM (VIAL)
12/23/2024
12/24/2024
IV
1.5g
Q8hrs
S/P NSD; UTI
Waiting Final Action 
12/23/2024
CEFUROXIME 500MG (TAB)
12/24/2024
12/31/2024
ORAL
500mg
BID
S/P NSD; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: